NKGen Biotech Inc (NASDAQ:NKGN) traded at $2.26 at last check on Wednesday, March 20, made an upward move of 6.60% on its previous day’s price.
Looking at the stock we see that its previous close was $2.12 and the beta (5Y monthly) reads 0.15. In terms of its 52-week price range, NKGN has a high of $12.88 and a low of $0.78. The company’s stock has gained about 79.37% over that past 30 days.
NKGen Biotech Inc has a market cap of $49.47 million.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the NKGN stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is 55.27% off its SMA20 and 24.13% from its 50-day simple moving average. The RSI (14) is pointing at 61.17 while the volatility over the past week is 24.91% and jumps to 33.92% over the past one month. The beta value is 0.34, while the average true range (ATR) is currently pointing at 0.48.
Coming back to NKGen Biotech Inc (NASDAQ:NKGN), we note that the average 3-month trading volume was 2.80 million, while that of the preceding 10-day period stands at 16.52 million. Current shares outstanding are 21.45 million.
The insiders hold 60.46% of the company’s shares while institutions hold 14.84%. The data shows that short shares as of Feb 29, 2024, stood at 0.34 million at a short ratio of 8.73. This represents a 1.53% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 0.31 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -17.82% down in year-to-date price movement.
